本文選題：兒童藥品 + 短缺　； 參考：《中國(guó)藥房》2017年33期

【摘要】：目的:為提高兒童藥品的供應(yīng)保障水平提供參考。方法:對(duì)江蘇省內(nèi)13家三級(jí)醫(yī)院的兒童藥品短缺情況及原因等進(jìn)行問(wèn)卷調(diào)查[主要面向各受訪醫(yī)院的藥學(xué)部主任(或藥品采購(gòu)人員)和臨床藥師],并就調(diào)查數(shù)據(jù)進(jìn)行統(tǒng)計(jì)和分析,進(jìn)而提出建議。結(jié)果:共發(fā)放問(wèn)卷26份,回收有效問(wèn)卷26份,有效回收率為100%。13家受訪醫(yī)院兒童專(zhuān)用藥品在各自醫(yī)院藥品目錄中的占比多數(shù)5%;共有82個(gè)兒童專(zhuān)用藥品品種(含醫(yī)院制劑),主要的3類(lèi)為中成藥(35.37%)、呼吸系統(tǒng)用藥(12.20%),以及維生素、礦物質(zhì)和腸內(nèi)腸外營(yíng)養(yǎng)藥(10.98%)。在126種短缺兒童藥品中,抗感染藥物、抗腫瘤藥物、神經(jīng)系統(tǒng)用藥和精神藥物、消化系統(tǒng)用藥短缺品種最多(均占8.73%)。在兒童藥品的短缺原因方面,價(jià)格因素(38.10%)、廠家停產(chǎn)(32.54%)及未中標(biāo)或無(wú)供應(yīng)(13.49%)等為主要原因;價(jià)格在0.01~10.00元的低價(jià)藥品短缺情況最為嚴(yán)重,占全部短缺品種的57.94%。受訪者認(rèn)為專(zhuān)科用藥短缺對(duì)臨床治療的影響最大(38.46%),其次為解毒藥(30.77%)和罕見(jiàn)病治療藥(15.38%)。結(jié)論:兒童專(zhuān)用藥品在醫(yī)院藥品目錄中占比很小,兒童藥品短缺受到多種因素影響,且低價(jià)藥品短缺情況尤其嚴(yán)重,兒童專(zhuān)科用藥和解毒藥的短缺被認(rèn)為對(duì)臨床治療的影響較大。建議通過(guò)制定兒童專(zhuān)用藥品保護(hù)性政策,改進(jìn)藥品流通環(huán)節(jié),促進(jìn)兒童藥物臨床試驗(yàn)開(kāi)展及加強(qiáng)兒童專(zhuān)用藥品研發(fā)等措施保障兒童藥品的供應(yīng)。
[Abstract]:Objective: to provide reference for improving the supply and security level of children's drugs. Methods: a questionnaire survey was conducted on the situation and causes of children's drug shortage in 13 tertiary hospitals in Jiangsu Province [mainly for pharmaceutical department directors (or drug purchasers) and clinical pharmacists in the hospitals interviewed], and the survey data were analyzed. Conduct statistics and analysis, And then put forward suggestions. Results: 26 questionnaires were distributed and 26 valid questionnaires were collected. The effective recovery rate was 100. 13 hospitals. The proportion of children's drugs in the list of medicines for children in their respective hospitals was 5 percent; there were 82 varieties of drugs for children (including hospital preparations, the main three categories were Chinese patent medicine (TCD) 35.37D, respiratory medicine was 12.20%), and vitamins, Minerals and parenteral nutrition 10.98%. Among 126 kinds of drugs for children, antiinfective drugs, antineoplastic drugs, nervous system drugs and psychotropic drugs, and digestive system drugs were the most common drugs (8.73%). In terms of the reasons for the shortage of children's drugs, the price factor is 38.10%, the manufacturer stops producing 32.54 parts) and the price is not awarded or no supply is 13.49%), and the low price medicine with price of 0.01 or 10.00 yuan is the most serious one, accounting for 57.94% of the total shortage varieties. The interviewees thought that the shortage of specialized drugs had the greatest effect on clinical treatment, followed by detoxification drug 30.77) and rare disease treatment drug 15.38%. Conclusion: the proportion of special drugs for children in the list of hospital drugs is very small. The shortage of children's drugs is affected by many factors, and the shortage of low price drugs is especially serious. Specialized drugs for children and a shortage of poisons are considered to have a greater impact on clinical treatment. It is suggested that some measures should be taken to ensure the supply of children's drugs, such as making protective policies for children's special drugs, improving the circulation of drugs, promoting the development of clinical trials of children's drugs and strengthening the research and development of children's special drugs.
【作者單位】： 南京醫(yī)科大學(xué)附屬兒童醫(yī)院;
【基金】：江蘇省衛(wèi)計(jì)委藥物政策研究課題(No.蘇衛(wèi)辦藥政[2016]5號(hào))
【分類(lèi)號(hào)】：R95

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 方曙，盛炳義，，江海碧;我國(guó)兒童藥品生產(chǎn)應(yīng)用的現(xiàn)狀和建議[J];中國(guó)藥事;1995年03期

2 劉強(qiáng);;我國(guó)兒童藥品存在問(wèn)題分析及建議[J];臨床合理用藥雜志;2012年27期

3 何淑旺;邱瓊;;歐盟兒童藥品管理的經(jīng)驗(yàn)及啟示[J];中國(guó)藥物評(píng)價(jià);2013年05期

4 國(guó)學(xué)瑞;;陜西省兒童藥品及醫(yī)療器械發(fā)展之我見(jiàn)[J];西北藥學(xué)雜志;1986年04期

5 孫笑寒;;兒童藥品包裝設(shè)計(jì)的人文關(guān)懷[J];遼寧工業(yè)大學(xué)學(xué)報(bào)(自然科學(xué)版);2013年02期

6 ;專(zhuān)家呼吁兒童藥審批亟待專(zhuān)門(mén)化[J];臨床合理用藥雜志;2013年20期

7 王文雪;劉p

本文編號(hào)：1891052